Dow is facing a lawsuit alleging its insecticide chlorpyrifos is linked to Parkinson’s disease. The suit claims Dow failed to disclose health risks tied to the product, raising questions around product safety and corporate conduct. Investors are assessing how this legal action could affect NYSE:DOW, including litigation exposure and reputational risk. For investors tracking Dow, the lawsuit comes at a time when the stock is trading at $30.79 and has fallen 14.5% over the past 30 days. Over...
News
High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.
144last 24h
877last 7d
147● bullish (7d)
98● bearish (7d)
214publishers
Simply Wall St.93d agobearish
Dow (DOW) Faces Parkinson’s Lawsuit Over Chlorpyrifos Safety Claims